Clinical Trials · NCT01455870
A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Intarcia Therapeutics
- Enrollment
- 535
- Start date
- May 2013
- Locations
- 54 sites, 5 countries
- Primary endpoint
- Change in HbA1c between Week 52 and Day 0